FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds (WSJ.com: US Business)

WSJ.com: US Business
FDA Moving to Authorize Pfizer-BioNTech Booster for 16-, 17-Year-Olds – The FDA could authorize Covid-19 boosters as soon as next week as concerns rise over the possible spread of a new, possibly more transmissible variant. …

Leave a Reply

Your email address will not be published. Required fields are marked *

Subscribe to our Newsletter